Clinical trials recruiting for Lung Cancer Stage II
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 1 |
| Certolizumab | 1 |
| Cisplatin | 1 |
| Gemcitabine | 1 |
| Nivolumab | 1 |
| Pemetrexed | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 2 |
| Massachusetts | 1 |
| New Jersey | 1 |
Top cities
Self-screener
Recruiting trials
- Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
- Avecure Flexible Microwave Ablation Probe For Lung Nodules
- COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
- Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
Related conditions
Trials recruiting for Lung Cancer Stage II often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Cancer Stage II trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.